SCHEMBL5573727

SCHEMBL5573727

COC(=O)[C@@H](O)Cc1ccc2c(c1)OCCO2

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
CYP3A4 P08684 2/20 0.48
MAPT P10636 2/20 0.45
TSHR P16473 1/20 0.45
ACACB O00763 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP2D6 P10635 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831335 0.84 SMN1; SMN2 (0.47) SMN1; SMN2CYP3A4MAPTTSHRACACB
SCHEMBL1744754 0.84 ALDH1A1 (0.52) SMN1; SMN2CYP3A4MAPTTSHRACACB
SCHEMBL1744756 0.84 ALDH1A1 (0.52) SMN1; SMN2CYP3A4MAPTTSHRACACB
SCHEMBL3350932 0.82 KDM6B (0.54) SMN1; SMN2CYP3A4TSHRNPC1RAB9A
SCHEMBL3350938 0.82 KDM6B (0.54) SMN1; SMN2CYP3A4TSHRNPC1RAB9A
SCHEMBL3359174 0.82 KDM6B (0.54) SMN1; SMN2CYP3A4TSHRNPC1RAB9A
SCHEMBL5571270 0.80 MEN1 (0.41) SMN1; SMN2MAPTTSHRNPC1RAB9A
SCHEMBL7831262 0.78 SMN1; SMN2 (0.41) SMN1; SMN2CYP3A4MAPTTSHRACACB
SCHEMBL27963133 0.78 CYP3A4 (0.56) SMN1; SMN2CYP3A4MAPTALDH1A1CYP2D6
SCHEMBL27963134 0.78 CYP3A4 (0.56) SMN1; SMN2CYP3A4MAPTALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740577-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-10 EP disclosed
WO-2005103037-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed